In closed communities such as the Amish in North America, rare genetic disorders occur more frequently. In children from this community, a condition has been described that affects the development of the nervous system and manifests, for example, as muscle weakness or epileptic seizures. The disorder is linked to a small change in a single protein, but for a long time it was unclear which cellular process this change disrupts. This question has now been answered by researchers from CEITEC Masaryk University, who show that the disease is caused by a disruption of a key mechanism required for the proper processing of genetic information in the cell.Every cell must first transcribe genetic information and then modify it before it can be used. From the original “working transcript,” unnecessary parts are removed and the remaining pieces are precisely joined together. This process, known as RNA splicing, consists of many consecutive steps and is tightly regulated. If the process does not proceed correctly or stops at any point, the cell cannot properly convert the copied genetic information into a usable form and therefore cannot function as it should.Researchers from CEITEC Masaryk University have now described one of the key steps in this process – a specific signal inside the cell. This signal acts as a checkpoint: only once it is fulfilled, the entire mechanism is activated and the process can continue.“We showed that during RNA splicing, a chemical modification of the protein SF3B1 is required at a precisely timed step. This modification allows another protein, SNIP1, to bind. If this signal is not transmitted correctly, the cell cannot proceed with the splicing process,” explains first author <a target="_blank" rel="noopener noreferrer" href="https://www.ceitec.eu/pavla-gajduskova-ph-d/u26136?page=publication">Pavla Gajdušková</a>.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_4_79e003984a.jpeg" alt="CEITEC: A Rare Genetic Disorder in the Amish Community Helped Confirm a Key Cellular Mechanism: Pavla Gajdušková" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_4_79e003984a.jpeg 235w," sizes="100vw" width="1600" height="1067">This is where the research connects to patients in the Amish community. In affected children, a small genetic change in the SNIP1 protein disrupts its ability to respond properly to the signal mediated by the modified SF3B1 protein, making RNA splicing less efficient than in healthy individuals. As a result, errors occur during RNA splicing that the cell cannot correct, impairing its function – especially in the nervous system.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_44a7e2ef17.jpg" alt="CEITEC/Blažek Lab: A Rare Genetic Disorder in the Amish Community Helped Confirm a Key Cellular Mechanism: Interaction between SF3B1 and SNIP1 proteins." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_44a7e2ef17.jpg 156w," sizes="100vw" width="1600" height="1600"><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_2_85826d711e.jpg" alt="CEITEC/Blažek Lab: A Rare Genetic Disorder in the Amish Community Helped Confirm a Key Cellular Mechanism: The effect of mutations in SNIP1 on cell proliferation." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_2_85826d711e.jpg 235w," sizes="100vw" width="1600" height="1067">The researchers were thus able to clarify the cause of this rare neurodevelopmental disorder. “Additionally, the cause of this disease also confirms the correctness of the checkpoint we described. It shows that even a small change in one of the proteins involved can disrupt the RNA splicing mechanism on which the cell depends,” adds group leader <a target="_blank" rel="noopener noreferrer" href="https://www.ceitec.eu/dalibor-blazek-ph-d/u25918">Dalibor Blažek</a>.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_3_f95cfd68eb.jpeg" alt="CEITEC/Martin Indruch: A Rare Genetic Disorder in the Amish Community Helped Confirm a Key Cellular Mechanism: Dalibor Blažek." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_CEITEC_Vzacna_geneticka_porucha_z_amisske_komunity_pomohla_potvrdit_klicovy_mechanismus_v_bunce_3_f95cfd68eb.jpeg 235w," sizes="100vw" width="1600" height="1067">Although the study focuses on basic research, its implications are broader. It suggests that the same mechanism may also play a role in regulating cell division – a process that is often disrupted in cancer.<blockquote>The research was carried out by scientists from CEITEC Masaryk University in collaboration with researchers from Spain and Germany. The study was published in the journal <a target="_blank" rel="noopener noreferrer" href="https://www.nature.com/articles/s41467-026-71119-2">Nature Communications</a>.</blockquote>

A Rare Genetic Disorder in the Amish Community Helped Confirm a Key Cellular Mechanism

This study investigates the pathogenesis of neurosyphilis through cerebrospinal fluid proteomics using LC–MS/MS and ELISA validation. Comparative analysis identified 234 differentially expressed proteins, with major alterations linked to lysosomal dysfunction, axon guidance, and neurodegeneration pathways.Key lysosomal proteins, including PSAP and DNASE2, together with the axonal protein EPHA4, were significantly downregulated in neurosyphilis patients. These proteins showed potential as biomarkers for neurodegeneration and may provide new insights into disease mechanisms, diagnostics, and therapeutic targets.<blockquote><h4>The original article</h4><h4><a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689">Cerebrospinal Fluid Proteome Reveals Dysregulation of Lysosomal and Axonal Proteins in Neurosyphilis</a></h4>Huayang Tang*, Junjie Hu, Yifan Wu, Jinping Gao, Wenjun Wang, Xiaodong Zheng, Ran Zhang, Bo Liang, Fusheng Zhou, Ze Guo*J. Proteome Res. 2026, 25, 2, 713–722<a target="_blank" rel="noopener noreferrer" href="https://doi.org/10.1021/acs.jproteome.5c00689">https://doi.org/10.1021/acs.jproteome.5c00689</a><h6>licensed under <a target="_blank" rel="noopener noreferrer" href="https://creativecommons.org/licenses/by/4.0/">CC-BY 4.0</a></h6></blockquote>Selected sections from the article follow. Formats and hyperlinks were adapted from the original.<div>Neurosyphilis (NS) is a group of clinical syndromes characterized by neuroinflammation caused by Treponema pallidum (T. pallidum), which occurs in all stages of syphilis. <a href="javascript:void(0);">(1,2)</a> NS is classified based on clinical presentation as either asymptomatic (ANS) or symptomatic (SNS), and based on disease stage as either early (occurring 1–2 years after primary infection) or late. <a href="javascript:void(0);">(1)</a> T. pallidum can cause local nonspecific and central nervous system (CNS) inflammation, leading to possible degenerative changes. <a href="javascript:void(0);">(3)</a> The immune response of CNS in neurosyphilis is comparable to that observed in other neuroinflammatory diseases. Consequently, the presence of neurological symptoms may not reliably indicate active CNS inflammation in syphilis patients. <a href="javascript:void(0);">(3)</a> A cerebrospinal fluid (CSF) proteomic study identified three biomarkers (SEMA7A, SERPINA3, and ITIH4) that contribute to NS and have potential implications for diagnosis and therapeutic strategies. <a href="javascript:void(0);">(4)</a> Through integrated proteomics and single-cell transcriptomics analyses, Toll-like/NF-κB signaling was identified as the key pathway involved in CNS damage caused by T. pallidum. <a href="javascript:void(0);">(5)</a> Despite an increasing understanding of the biomarkers and possible neuroinflammatory damage mechanisms of neurosyphilis, the mechanisms of neurodegeneration caused by T. pallidum infection remain elusive. <a href="javascript:void(0);">(6)</a>Patients with neurosyphilis exhibit stage-specific profiles of soluble factors in their CSF, which are linked to both immune status and the extent of neuronal damage. <a href="javascript:void(0);">(7)</a> In this study, we analyzed differentially expressed proteins (DEPs) in the CSF proteomes from 28 individuals, including neurosyphilis (NS), suspected neurosyphilis (spNS) and non-neurosyphilis (nNS) individuals, by LC–MS/MS and analyzed a public data set of the neurosyphilis CSF proteome. Validation was then performed by ELISA in an independent group comprising 110 samples. The results revealed that neuroinflammation by T. pallidum infection results in dysregulation of the key proteins in lysosomal and axonal pathway, which suggesting a potential contribution to neurodegeneration in neurosyphilis.<h4>Materials and Methods</h4><h5>LC–MS/MS</h5>The tryptic peptides were dissolved in 0.1% formic acid (solvent A) and loaded onto a custom-made reversed-phase column (15 cm × 75 μm). Using an EASY-nLC 1000 UPLC system, a gradient was run at 400 nL/min as follows: 6% to 23% solvent B (0.1% formic acid in 98% acetonitrile) over 26 min, 23% to 35% in 8 min, up to 80% in 3 min, and held at 80% for 3 min. Peptides were ionized via an NSI source at 2.0 kV and analyzed online by a <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/559">Q Exactive Plus mass spectrometer</a>. Full scans (m/z 350–1800) were acquired in the Orbitrap at 70,000 resolution. The top precursors were selected for MS/MS with an NCE of 28, and fragments were detected at 17,500 resolution. A data-dependent method cycled between one MS scan and 20 MS/MS scans with a 15.0 s dynamic exclusion. AGC was set at 5E4. MS/MS data were processed with MaxQuant (v.1.5.2.8) using Trypsin/P as the enzyme (up to 2 missed cleavages). Precursor mass tolerance was 20 ppm (first search) and 5 ppm (main search); fragment mass tolerance was 0.02 Da. Fixed modification: carbamidomethyl (C); variable modification: oxidation (M). The FDR threshold was &lt;1%, and the minimum peptide score was &gt;40.<h5>ELISA</h5>CSF levels of host proteins were quantified using commercial ELISA kits according to the manufacturers’ protocols. Proteins analyzed included PSAP (OKEH07124, Aviva, USA), CTSL (abx150963, Abbexa, UK), NPC2 (A-QEK07857, Biogradetech, USA), and DNASE2 (abx386953, Abbexa, UK). Briefly, 100 μL of CSF was added to precoated plates and incubated at 37 °C for 2 h. After washing, 100 μL of detection antibody was added to each well and incubated at 37 °C for another 2 h. Following a wash, 100 μL of streptavidin-HRP working solution was added and incubated at room temperature for 20 min in the dark. The reaction was stopped with 50 μL of stop solution, and the optical density was measured at 450 nm.<h4>Results</h4><h5>Downregulation of Key Lysosomal Proteins in CSF from Patients With Neurosyphilis</h5>By analyzing the DEPs in NS vs nNS, we observed a significant enrichment of downregulated proteins in the lysosome pathway (P = 0.007) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>A), with 9 lysosomal proteins showing significant downregulation (Padj &lt; 0.05) in the NS group (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S4</a>). To validate this finding, we examined the public CSF proteomics data set of neurosyphilis (PXD033034) and identified 18 proteins in the lysosomal pathway that were significantly downregulated in patients with NS (Padj &lt; 0.05) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S4</a>). PPI network analysis determined the top 10 hub genes within the lysosome pathway (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>B). A Venn diagram revealed 3 proteins (PSAP, CTSL, and NPC2) shared across our current data, the public data set (PXD033034) and the top 10 hub genes (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>C). The mass spectrometry results indicated that the levels of PSAP (Padj = 0.043), CTSL (Padj = 0.028) and NPC2 (Padj = 0.013) were significantly lower in the NS group compared to the nNS group (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>D). The PXD033034 data set revealed consistent changes in the PSAP, CTSL, and NPC2 levels in the NS group (Padj &lt; 0.05) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Figure S1 and Table S4</a>). In addition, associations between the lysosomal protein DNASE2 and NS were observed in both the present study (Padj = 0.003) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>D) and the PXD033034 data set (Padj &lt; 0.05) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Figure S1 and Table S4</a>), with subgroup analysis revealing a significantly lower expression level of DNASE2 in the SNS group compared to the ANS group (P = 0.035) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>D and <a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S3</a>). Further validation by ELISA (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S5</a>) in an independent group (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#tbl1">Table 1</a>) confirmed significantly downregulated CSF levels of PSAP (P &lt; 0.0001), CTSL (P &lt; 0.0001), NPC2 (P = 0.0024) and DNASE2 (P &lt; 0.0001) in patients with NS (n = 21) than in nNS individuals (n = 56) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>E) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S6</a>), as well as decreased in the SNS subgroup (P &lt; 0.05) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Figure S2 and Table S6</a>). Receiver operating characteristic (ROC) curve analysis supported PSAP (AUC = 0.91, 95% CI: 0.83–0.99) and DNASE2 (AUC = 0.95, 95% CI: 0.91–0.99) for distinguishing NS from nNS and as potential biomarkers for assessing neurodegeneration in NS (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>F). These results indicate that T. pallidum infection may lead to lysosomal dysfunction in CNS.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/J_Proteome_Res_2026_25_2_713_722_Figure_2_Downregulation_of_key_lysosomal_proteins_in_the_cerebrospinal_fluid_of_neurosyphilis_patients_bbccd95f44.jpg" alt="J. Proteome Res. 2026, 25, 2, 713–722: Figure 2. Downregulation of key lysosomal proteins in the cerebrospinal fluid of neurosyphilis patients. (a) KEGG pathway analysis demonstrated that downregulated proteins in patients with NS were significantly enriched in the lysosome pathway, as well as in axon guidance and neurodegeneration. (b) The top 10 hub genes involved in the lysosome pathway were identified using the STRING network data set and PPI analysis. (c) A Venn diagram revealed 3 proteins (PSAP, CTSL, and NPC2) shared across our current data, the public data set (PXD033034) and the top 10 hub genes. (d) The CSF levels of PSAP (Padj = 0.043), CTSL (Padj = 0.028), DNASE2 (Padj = 0.003) and NPC2 (Padj = 0.013) were significantly decreased in the NS group than in the nNS group. Subgroup analysis found a significantly lower expression level of DNASE2 in the SNS group than in the ANS group (P = 0.035). (e) PSAP, DNASE2, CTSL and NPC2 levels in CSF were tested by ELISA in the nNS (n = 56) and NS (n = 21) groups. Compared with those in the nNS group, significantly lower PSAP (P &lt; 0.0001), CTSL (P &lt; 0.0001), DNASE2 (P &lt; 0.0001) and NPC2 (P = 0.0024) levels were detected in the NS group. (f) ROC curve analysis for NS revealed that PSAP had an AUC = 0.91 (95% CI: 0.83–0.99), DNASE2 had an AUC = 0.95 (95% CI: 0.91–0.99), CTSL had an AUC = 0.85 (95% CI: 0.76–0.95), and NPC2 had an AUC = 0.72 (95% CI: 0.59–0.85). NS: neurosyphilis; nNS: non-neurosyphilis; ANS: asymptomatic neurosyphilis; SNS: symptomatic neurosyphilis. ROC: receiver operating characteristic; AUC: area under the curve. * P &lt; 0.05, ** P &lt; 0.01, ****P &lt; 0.0001." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_J_Proteome_Res_2026_25_2_713_722_Figure_2_Downregulation_of_key_lysosomal_proteins_in_the_cerebrospinal_fluid_of_neurosyphilis_patients_bbccd95f44.jpg 140w," sizes="100vw" width="2100" height="2339"><h5>Downregulation of Key Axonal Proteins Correlated with Lysosomal Protein Reduction in Neurosyphilis CSF</h5>Lysosomes play crucial roles in neuronal health by maintaining axonostasis. <a href="javascript:void(0);">(10)</a> The enrichment analysis indicated that the downregulated proteins in NS were implicated in the biological processes of axonostasis (such as axon development and axonogenesis) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig1">Figure 1</a>F) and the pathway of axon guidance (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig2">Figure 2</a>A). Our proteomic data revealed a total of 24 downregulated (Padj &lt; 0.05) axonal proteins and 1 upregulated (Padj &lt; 0.05) axonal protein in the CSF of patients with NS (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S9</a>). Furthermore, the PXD033034 data set revealed 55 downregulated (Padj &lt; 0.05) and 4 upregulated (Padj &lt; 0.05) axonal proteins in NS (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.5c00689/suppl_file/pr5c00689_si_001.zip">Table S9</a>). The top 10 hub genes involved in the biological processes of axon development and axonogenesis were identified by PPI network analysis (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig4">Figure 4</a>A). Considering the overlap of our current data, the PXD033034 data set and the top 10 hub genes (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig4">Figure 4</a>B), one key protein, EPHA4, was identified across 3 data sets, with significant downregulation in our current data (Padj = 0.011) and in the PXD033034 data set (Padj = 0.028) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig4">Figure 4</a>C). Correlation analysis further revealed a positive correlation between the levels of PSAP and EPHA4 (r = i 0.83, P &lt; 0.05) (<a target="_blank" rel="noopener noreferrer" href="https://pubs.acs.org/doi/10.1021/acs.jproteome.5c00689#fig4">Figure 4</a>D). Reduced levels of PSAP and EPHA4 in CSF have been implicated in neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). <a href="javascript:void(0);">(11,12)</a> Our findings suggest that coordinated dysregulation of lysosomal and axonal proteins may contribute to neurodegeneration in NS.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/J_Proteome_Res_2026_25_2_713_722_Figure_4_Key_axonal_protein_downregulated_in_CSF_from_patients_with_neurosyphilis_66f5533e94.jpg" alt="J. Proteome Res. 2026, 25, 2, 713–722: Figure 4. Key axonal protein downregulated in CSF from patients with neurosyphilis. (a) The top 10 hub genes involved in axonostasis were identified by the STRING network data set and PPI analysis. (b) A Venn diagram revealed 1 protein (EPHA4) shared across DEPs related to axonostasis in our current data and in the public data set (PXD033034) and the top 10 hub genes. (c) EPHA4 was significantly downregulated both in our present study (Padj = 0.011) and in the PXD033034 data set (Padj = 0.028). (d) Correlation analysis demonstrated that the EPHA4 level was significantly positively correlated (P &lt; 0.05) with the levels of PSAP (r = 0.83), CTSL (r = 0.6), NPC2 (r = 0.69), DNASE2 (r = 0.61) and SEMA7A (r = 0.83). NS: neurosyphilis; nNS: non-neurosyphilis. * P &lt; 0.05." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_J_Proteome_Res_2026_25_2_713_722_Figure_4_Key_axonal_protein_downregulated_in_CSF_from_patients_with_neurosyphilis_66f5533e94.jpg 178w," sizes="100vw" width="1250" height="1096"><h4>Conclusions</h4>The present study reveals the associations of dysregulated proteins in lysosomal and axonal pathways with neurosyphilis, and potential evidence of shared pathophysiological mechanisms between neuroinflammation caused by T. pallidum infection and neurodegenerative diseases.However, this study has certain limitations. First, the use of ELISA to validate a limited number of proteins has certain limitations, such as the inherent cross-reactivity of ELISA. In the future, we can optimize the validation experiments by adding techniques such as Western blotting for verification. Second, this study uses a cross-sectional sampling method for research, which limits our ability to infer disease progression and treatment responses. In the future, we will conduct follow-up on the subjects, continue collecting cerebrospinal fluid samples after treatment, and observe whether the protein dysregulation is reversible after treatment. For spNS patients, follow-up should also be conducted to determine if they have transformed into NS, which will be very valuable for validating the predictive utility of our biomarkers. Finally, although multiple discovery and validation cohort studies have been conducted, we currently lack direct mechanistic evidence. Future work will investigate whether exposing neural cell coculture models to outer-membrane antigens of T. pallidum reproduces the lysosome and axon alterations observed in CSF, clarifying their role in neural damage of neurosyphilis and potential biomarkers for diagnosis and treatment of neurodegeneration in neurosyphilis.</div>

Cerebrospinal Fluid Proteome Reveals Dysregulation of Lysosomal and Axonal Proteins in Neurosyphilis

In the week of May 11, the following webinars await you in the field of liquid phase and especially HPLC and LC/MS.<blockquote><h4><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinars">👉 DETAILS AND REGISTRATION IN THE WEBINARS SECTION</a></h4>👉 Search and filter in the largest global database with over 5 500 GC, LC, MS and spectroscopy webinars.</blockquote><h5>1. Thermo Fisher Scientific: Uncovering Microplastics: Identification, Quantification, and Exposure Assessment</h5><ul><li>Tu, 12.5.2026 08:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6136">Registration</a></li></ul>In this webinar, we will explore complementary analytical solutions for comprehensive microplastics characterization.<h5>2. Waters Corporation: Size variant analysis of antibodies and ADCs using SEC, SEC-MALS, SEC-MS, and 2D Protein A-SEC Methods</h5><ul><li>Tu, 12.5.2026 17:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6169">Registration</a></li></ul>Size-exclusion chromatography (SEC) is essential for analyzing aggregates, monomers, and fragments in biotherapeutic proteins.<h5>3. Waters Corporation: Beyond C18 and Phenyl: Expanding Selectivity with Biphenyl Columns Built for UV and pH Robustness</h5><ul><li>We, 13.5.2026 16:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6183">Registration</a></li></ul>Discover how modern biphenyl stationary phases improve challenging LC separations with lower UV bleed, broad pH stability, and enhanced recovery of metal-sensitive analytes.<h5>4. Milestone: Modern Sample Prep for Organic Contaminants: PAHs, PFAS, MOSH/MOAH in Food</h5><ul><li>We, 13.5.2026 16:00 CET</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/5822">Registration</a></li></ul>Learn how microwave-assisted extraction streamlines food analysis of PAHs, PFAS, and MOSH/MOAH, improving recoveries, reducing solvents, and meeting regulatory demands.<h5>5. SelectScience: Achieve faster GLP-1 amino acid analysis with rapid UPLC technology</h5><ul><li>We, 13.5.2026 17:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6173">Registration</a></li></ul>Accelerate GLP-1 amino acid analysis. Learn how UPLC, microwave hydrolysis and Waters AccQ-Tag solutions speed up drug development and ensure compliance.<h5>6. Waters Corporation: Transform Your Daily Lab Operations with Automation - Biomolecules Workflows</h5><ul><li>Th, 14.5.2026 11:00 CEST</li><li><a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/webinar/6174">Registration</a></li></ul>Discover how Andrew+ and OneLab automate complex biomolecule workflows. Learn how labs improve consistency, traceability, and efficiency in oligonucleotide and peptide analysis.

Webinars LabRulezLCMS Week 20/2026

Article

Webinars

Health

Scientific article

Science and research

Since its establishment in 2011, CEITEC has quickly developed into a cutting-edge infrastructure for research which performs highly alongside the best institutes in Europe. Among the main priorities of CEITEC are the promotion of a motivating and dynamic international scientific environment, the provision of state-of-the-art research infrastructure, and the policy of open communication and equal opportunities.

CEITEC

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

KNAUER AZURA® Compact Prep HPLC System

The AZURA® Prep Compact system is the perfect start into preparative chromatography. With the complete, semi-preparative HPLC system you master your isocratic purification tasks.

AZURA® Preparative HPLC Customized purificationAZURA® preparative systems are the perfect solution for frequently changing separation tasks – from milligram to kilogram scale. Design your AZURA preparative system to your needs and combine flexibility and reliability.<h5>Customaze your system</h5>AZURA® Prep systems are tailor-made for you. Configure your system from injection to detection and choose between different materials, flow rates, valves, and detectors.<h5>Easy scale up from compact to pilot systems</h5>Due to the flexible design of our devices, you can easily change parts like pump heads or flow cells and integrate all components of the compact into the pilot-scale system.<h5>Stacked injections, peak &amp; solvent recycling</h5>AZURA® Prep systems can be used for special separation modes like peak recycling and stacked injections. We help you to configure your system and choose the best software for you.<h3>Flexibility and performance</h3><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Prep_HPLC_System_90fef641c3.jpg" alt="KNAUER AZURA® Prep HPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Prep_HPLC_System_90fef641c3.jpg 245w," sizes="100vw" width="1920" height="1059"><h2>AZURA® Compact Prep HPLC System</h2>The AZURA® Prep Compact system is the perfect start into preparative chromatography. With the complete, semi-preparative HPLC system you master your isocratic purification tasks.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Compact_Prep_HPLC_System_3_863a93178e.jpg" alt="KNAUER: AZURA® Compact Prep HPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Compact_Prep_HPLC_System_3_863a93178e.jpg 245w," sizes="100vw" width="1590" height="604"><h4>Compact Prep System</h4>One manual injection can purify several hundred milligrams at up to 50 ml/min. Detection takes place via a versatile UV/VIS detector. The intuitive preparative software PurityChrom controls the compact system and regulates the fraction collection via a 12-port fractionating valve. Thanks to its compact design, the AZURA Prep Compact system finds its place in every laboratory.<img style="aspect-ratio:1024/742;" src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Compact_Prep_HPLC_System_48291f6f6e.webp" alt="KNAUER: AZURA® Compact Prep HPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Compact_Prep_HPLC_System_48291f6f6e.webp 215w," sizes="100vw" width="1024" height="742"><ul><li>Up to 150 bar</li><li>Complete semi-preparative isocratic HPLC system with low space requirements</li><li>Up to 10 ml injection volumes &nbsp;</li><li>Injection valve incl. 500 μl sample loop&nbsp;</li><li>Collect up to 16 large fractions</li><li>Columns from 4–20 mm ID</li><li>UV/VIS detector with one variable wavelength</li><li>Intuitive PurityChrom®, MobileControl® software</li><li>Compact and expandable</li></ul><h3>Easy upgrade without big investment</h3><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Compact_Prep_HPLC_System_4_efed81c462.jpg" alt="KNAUER: AZURA® Compact Prep HPLC System: Easy upgrade without big investment." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Compact_Prep_HPLC_System_4_efed81c462.jpg 245w," sizes="100vw" width="1600" height="761"><h4>Pilot Prep System</h4><div><div data-message-author-role="assistant" data-message-id="efe48b67-eccf-4ebf-8484-ea6d1f96ed57" dir="auto" data-message-model-slug="gpt-4o"><div><div>After starting preparative chromatography with the space-saving prep system, the requirements for your purification tasks can quickly increase. The existing Compact System (50 ml/min) can be expanded to a Pilot System (220 ml/min) by investing in a fraction collector and a preparative pump. All components of the Compact System are fully integrated into the Pilot System.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Compact_Prep_HPLC_System_2_d713ad0086.jpg" alt="KNAUER: AZURA® Compact Prep HPLC System: Easy upgrade without big investment." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Compact_Prep_HPLC_System_2_d713ad0086.jpg 178w," sizes="100vw" width="1606" height="1407"><ul><li>Pilot Ternary gradient HPLC system with injection valve incl. 500 μl sample loop&nbsp;</li><li>Sample pump with automatic sample selection&nbsp;</li><li>UV/VIS detector&nbsp;with one variable wavelength</li><li>Intuitive PurityChrom® software</li><li>Fraction collector</li></ul></div></div></div></div>

KNAUER AZURA® Bio Compact AC FPLC System

The AZURA Compact AC system qualifies for fast and reliable affinity chromatography. 

KNAUER protein purification: The flexible FPLC platformAZURA® Bio purification systems&nbsp;complete solutions for FPLC on a minimum footprint: AZURA FPLC systems combine flexibility and reliability. The biocompatible/metal-free FPLC is the perfect choice for your protein purification task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg" alt="KNAUER: AZURA® Bio Compact AC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg 245w," sizes="100vw" width="1506" height="600">Design your AZURA Bio purification system to fit your needs. Multiple functionalities such as automatic sample injection via autosampler, column switching, buffer and sample selection, and fraction collection enable automation of the purification process.A wide range of detectors ensures the visibility of target molecules. Various flow rates and compatibility with columns from all vendors provide maximum flexibility. The intuitive PurityChrom® software integrates all the advantages of a versatile purification system.<h3>AZURA® Bio Compact AC FPLC System</h3><h4>For affinity chromatography</h4>The AZURA Compact AC system qualifies for fast and reliable affinity chromatography. Select your sample, washing, and elution buffer using the selection valve. Your proteins of interest are detected by UV and automatically collected via the fractionation valve.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_4_bef2309e7d.jpg" alt="KNAUER: AZURA® Bio Compact AC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_4_bef2309e7d.jpg 245w," sizes="100vw" width="1666" height="513"><h3>Key features</h3><ul><li data-start="93" data-end="153">Flow rate: 0.01–50 ml/min (recommended: 1–40 ml/min)</li><li data-start="154" data-end="193">Maximum system pressure: 50 bar</li><li data-start="194" data-end="278">Sample and buffer selection: Automatic valve for up to 12 buffers or samples</li><li data-start="279" data-end="349">Detection: Variable single wavelength UV detector (190–500 nm)</li><li data-start="350" data-end="429">Column compatibility: Compatible with affinity columns from all vendors</li><li data-start="430" data-end="574">Fraction collection: 16-port fractionation valve, capable of collecting up to 16 fractions for flow-through, wash, and elution fractions</li><li data-start="575" data-end="663">Software: Intuitive and powerful PurityChrom® software, 21 CFR Part 11 compliant</li><li data-start="664" data-end="737">Affinity purification: Designed for tagged proteins or antibodies</li><li data-start="738" data-end="867">Compact system: User-friendly and cost-efficient, with the ability to upgrade for more complex protein purification tasks</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_5_17f4f13731.jpg" alt="KNAUER AZURA® Bio Compact AC FPLC System: Protein purification based on high affinity Chromatogram &amp; Legend." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_5_17f4f13731.jpg 209w," sizes="100vw" width="1024" height="766">&nbsp;

KNAUER AZURA® Bio Compact SEC FPLC System

AZURA Compact SEC systems handle time-consuming SEC methods in your lab without occupying your valuable FPLC system.

KNAUER protein purification: The flexible FPLC platformAZURA® Bio purification systems&nbsp;complete solutions for FPLC on a minimum footprint: AZURA FPLC systems combine flexibility and reliability. The biocompatible/metal-free FPLC is the perfect choice for your protein purification task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg" alt="KNAUER: AZURA® Bio Compact AC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg 245w," sizes="100vw" width="1506" height="600">Design your AZURA Bio purification system to fit your needs. Multiple functionalities such as automatic sample injection via autosampler, column switching, buffer and sample selection, and fraction collection enable automation of the purification process.A wide range of detectors ensures the visibility of target molecules. Various flow rates and compatibility with columns from all vendors provide maximum flexibility. The intuitive PurityChrom® software integrates all the advantages of a versatile purification system.<h3>AZURA® Bio Compact SEC FPLC System</h3><h4>For Size Exclusion Chromatography (SEC)</h4>AZURA Compact SEC systems take over time-consuming SEC methods in your lab without blocking your valuable FPLC system. Due to its compact design and intuitive FPLC software PurityChrom®, the system offers outstanding performance and ease of use.&nbsp;Pre-designed methods are included in the software for the designated SEC system and can be easily adapted by changing the column volume. AZURA Compact SEC supports all columns available on the market.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_SEC_FPLC_System_4_f5efb08061.jpg" alt="KNAUER: AZURA® Bio Compact SEC FPLC System " srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_SEC_FPLC_System_4_f5efb08061.jpg 245w," sizes="100vw" width="1358" height="540"><h3>Key features</h3><ul><li data-start="93" data-end="157">Flow rate: 0.001–10 ml/min (recommended: 0.1–8.0 ml/min)</li><li data-start="158" data-end="197">Maximum system pressure: 50 bar</li><li data-start="198" data-end="276">Injection system: Injection valve for sample injection via sample loop</li><li data-start="277" data-end="347">Detection: Variable single wavelength UV detector (190–500 nm)</li><li data-start="348" data-end="423">Fraction collection: Fraction collector for automated fractionation</li><li data-start="424" data-end="522">Column compatibility: Supports columns from all vendors, including third-party SEC columns</li><li data-start="523" data-end="611">Software: Intuitive and powerful PurityChrom® software, 21 CFR Part 11 compliant</li><li data-start="612" data-end="780">System design:<ul data-start="637" data-end="780"><li data-start="637" data-end="666">Isocratic buffer delivery</li><li data-start="669" data-end="687">Loop injection</li><li data-start="690" data-end="734">Wide range of collection racks available</li><li data-start="737" data-end="780">Specially designed for SEC applications</li></ul></li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_SEC_FPLC_System_3_7a4bc1f60b.jpg" alt="KNAUER: AZURA® Bio Compact SEC FPLC System " srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_SEC_FPLC_System_3_7a4bc1f60b.jpg 245w," sizes="100vw" width="1920" height="1152">Don't use your valuable gradient FPLC system for boring and time-consuming size exclusion separations. Choose your dedicated AZURA SEC system.<figure class="image"><img style="aspect-ratio:690/490;" src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_SEC_FPLC_System_45d5079064.webp" alt="KNAUER: AZURA® Bio Compact SEC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_SEC_FPLC_System_45d5079064.webp 220w," sizes="100vw" width="690" height="490"></figure>With its compact design and intuitive software, the system offers excellent performance, ease of use and supports all SEC columns available on the market.​

KNAUER AZURA® Bio Lab FPLC System

AZURA Bio Lab allows you to create FPLC systems with highest independence. Just pick your modules and build-up the system yourself. The intuitive software PurityChrom will be flexibly adjusted to your system.

KNAUER protein purification: The flexible FPLC platformAZURA® Bio purification systems&nbsp;complete solutions for FPLC on a minimum footprint: AZURA FPLC systems combine flexibility and reliability. The biocompatible/metal-free FPLC is the perfect choice for your protein purification task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg" alt="KNAUER: AZURA® Bio Compact AC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg 245w," sizes="100vw" width="1506" height="600">Design your AZURA Bio purification system to fit your needs. Multiple functionalities such as automatic sample injection via autosampler, column switching, buffer and sample selection, and fraction collection enable automation of the purification process.A wide range of detectors ensures the visibility of target molecules. Various flow rates and compatibility with columns from all vendors provide maximum flexibility. The intuitive PurityChrom® software integrates all the advantages of a versatile purification system.<h3>AZURA® Bio Lab FPLC System</h3><h4>R&amp;D-scale gradient system for complex purifications of bio molecules</h4>AZURA Bio Lab allows you to create FPLC systems with highest independence. Just pick your modules and build-up the system yourself. The intuitive software PurityChrom will be flexibly adjusted to your system.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_FPLC_System_3_7b22a3e099.jpg" alt="KNAUER: AZURA® Bio Lab FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_FPLC_System_3_7b22a3e099.jpg 245w," sizes="100vw" width="1645" height="671"><h3>Key features</h3><ul><li data-start="93" data-end="145">Flow rate: 0.001–50 ml/min (maximum 240 bar)</li><li data-start="146" data-end="224">Injection system: Sample injections via sample loop and/or sample pump</li><li data-start="225" data-end="295">Detection: Variable single wavelength UV detector (190–500 nm)</li><li data-start="296" data-end="386">Fraction collection: XY fraction collector for large volumes or numerous fractions</li><li data-start="387" data-end="493">Column compatibility: Supports up to 7 columns for method development – all FPLC columns supported</li><li data-start="494" data-end="584">Suitable for Ion-exchange, HILIC, affinity, SEC, and RP</li><li data-start="585" data-end="640">Reproducible and automated protein purification</li><li data-start="641" data-end="695">System usability: Suitable for cold room usage</li><li data-start="696" data-end="820">Software:<ul data-start="716" data-end="820"><li data-start="716" data-end="780">Intuitive and powerful PurityChrom® software (basic license)</li><li data-start="783" data-end="820">21 CFR Part 11 compliant software</li></ul></li><li data-start="821" data-end="924">Additional features:<ul data-start="852" data-end="924"><li data-start="852" data-end="924">Conductivity and pH-monitoring, pressure, and air sensors (optional)</li></ul></li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_FPLC_System_4740938659.jpg" alt="KNAUER: AZURA® Bio Lab FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_FPLC_System_4740938659.jpg 235w," sizes="100vw" width="1920" height="1279">From simple to advanced, from lab to process scale – configure your FPLC with our modular design according to your purification needs.Designed and optimized for all FPLC applications such as affinity, ion exchange, hydrophobic interaction and size exclusion chromatography. All system modules can be expanded with additional modules.

KNAUER AZURA® Bio Lab Advanced FPLC System

Gradient-capable FPLC system for a wide range of purifications including automated two-step applications

KNAUER protein purification: The flexible FPLC platformAZURA® Bio purification systems&nbsp;complete solutions for FPLC on a minimum footprint: AZURA FPLC systems combine flexibility and reliability. The biocompatible/metal-free FPLC is the perfect choice for your protein purification task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg" alt="KNAUER: AZURA® Bio Compact AC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg 245w," sizes="100vw" width="1506" height="600">Design your AZURA Bio purification system to fit your needs. Multiple functionalities such as automatic sample injection via autosampler, column switching, buffer and sample selection, and fraction collection enable automation of the purification process.A wide range of detectors ensures the visibility of target molecules. Various flow rates and compatibility with columns from all vendors provide maximum flexibility. The intuitive PurityChrom® software integrates all the advantages of a versatile purification system.<h3>AZURA® Bio Lab Advanced FPLC System</h3><h4>Gradient-capable FPLC system for a wide range of purifications including automated two-step applications</h4>Protein purification involves most of the times two to three steps:<ol><li>capture step</li><li>optional intermediated step</li><li>polishing step</li></ol>The transition from one to another step generally involves manual interaction and thus is time-consuming. Automation by combining these steps increases the efficiency and optimizes the workflow.&nbsp;The quick and automated linkage of multiple chromatographic purification steps into one method eliminates manual sample handling and minimizes time spent between steps. This automation strategy can be easily adapted to each purification task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_FPLC_System_3_7b22a3e099.jpg" alt="KNAUER: AZURA® Bio Lab Advanced FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_FPLC_System_3_7b22a3e099.jpg 245w," sizes="100vw" width="1645" height="671"><h3>Key features</h3><ul data-start="93" data-end="1077"><li data-start="93" data-end="144">Flow rate: 0.001–50 ml/min (maximum 50 bar)</li><li data-start="145" data-end="263">Injection system: Sample injection via loop or sample pump, with automated storage and reinjection of proteins</li><li data-start="264" data-end="433">Detection system:<ul data-start="292" data-end="433"><li data-start="292" data-end="320">Multichannel UV detector</li><li data-start="323" data-end="405">Highly sensitive multi-wavelength detector for proteins, DNA/RNA, and peptides</li><li data-start="408" data-end="433">Conductivity detector</li></ul></li><li data-start="434" data-end="566">Fraction collection: XY fraction collector with outlet valve for automated collection of large volumes or numerous fractions</li><li data-start="567" data-end="673">Column compatibility: Supports up to 7 columns for method development – all FPLC columns supported</li><li data-start="674" data-end="764">Suitable for Ion-exchange, HILIC, affinity, SEC, and RP</li><li data-start="765" data-end="864">Automation: Enables challenging protein purification tasks with minimal manual intervention</li><li data-start="865" data-end="973">Software:<ul data-start="885" data-end="973"><li data-start="885" data-end="933">Intuitive and powerful PurityChrom® software</li><li data-start="936" data-end="973">21 CFR Part 11 compliant software</li></ul></li><li data-start="974" data-end="1077">Additional features:<ul data-start="1005" data-end="1077"><li data-start="1005" data-end="1077">Conductivity and pH-monitoring, pressure, and air sensors (optional)</li></ul></li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_Advanced_FPLC_System_3_9cf517ceaf.webp" alt="KNAUER: AZURA® Bio Lab Advanced FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_Advanced_FPLC_System_3_9cf517ceaf.webp 234w," sizes="100vw" width="690" height="460"><h3>Two-step purification: Special multi-column chromatography solutions</h3>Designed and optimized for all FPLC applications such as affinity, ion exchange, hydrophobic interaction and size exclusion chromatography. In addition, you can perform dedicated twoSTEP applications.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_Advanced_FPLC_System_44bff80cfc.webp" alt="KNAUER: AZURA® Bio Lab Advanced FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_Advanced_FPLC_System_44bff80cfc.webp 209w," sizes="100vw" width="1920" height="1434"><h3>Automated two-step purification of mouse IgG antibodies</h3><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_Advanced_FPLC_System_4_c86d2177ce.jpg" alt="KNAUER: AZURA® Bio Lab Advanced FPLC System: The affinity chromatography step was automatically combined with a gel filtration step to exchange the buffer of the purified mouse IgG antibodies; Phase 1: Column equilibration, Phase 2: Sample injection and washing, Phase 3: Elution of IgG from protein A column, Phase 4: Desalting of IgG." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_Advanced_FPLC_System_4_c86d2177ce.jpg 245w," sizes="100vw" width="1085" height="605">

KNAUER AZURA® Bio Lab Pilot FPLC System

Configure your FPLC system based on your purification requirements. The Pilot system is designed for scale-up and process applications. All system modules can be expanded with additional modules.

KNAUER protein purification: The flexible FPLC platformAZURA® Bio purification systems&nbsp;complete solutions for FPLC on a minimum footprint: AZURA FPLC systems combine flexibility and reliability. The biocompatible/metal-free FPLC is the perfect choice for your protein purification task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg" alt="KNAUER: AZURA® Bio Compact AC FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Compact_AC_FPLC_System_6_a874551078.jpg 245w," sizes="100vw" width="1506" height="600">Design your AZURA Bio purification system to fit your needs. Multiple functionalities such as automatic sample injection via autosampler, column switching, buffer and sample selection, and fraction collection enable automation of the purification process.A wide range of detectors ensures the visibility of target molecules. Various flow rates and compatibility with columns from all vendors provide maximum flexibility. The intuitive PurityChrom® software integrates all the advantages of a versatile purification system.<h3>AZURA® Bio Lab Pilot FPLC System</h3><h4>High Flow Bio Purification FPLC System – up to 1000 ml/min</h4>Configure your FPLC system based on your purification requirements. The Pilot system is designed for scale-up and process applications. All system modules can be expanded with additional modules.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_Bio_Lab_Pilot_FPLC_System_e208baf41d.jpg" alt="KNAUER: AZURA® Bio Lab Pilot FPLC System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_Bio_Lab_Pilot_FPLC_System_e208baf41d.jpg 156w," sizes="100vw" width="1000" height="1000"><h3>Key features</h3><ul data-start="93" data-end="1069"><li data-start="93" data-end="129">Flow rate: 0.001–1000 ml/min</li><li data-start="130" data-end="192">Injection system: Sample pump for large sample volumes</li><li data-start="193" data-end="351">Detection system:<ul data-start="221" data-end="351"><li data-start="221" data-end="276">Variable single wavelength UV detector (190–500 nm)</li><li data-start="279" data-end="351">Conductivity and pH-monitoring, pressure, and air sensors (optional)</li></ul></li><li data-start="352" data-end="465">Fraction collection: XY fraction collector for reliable collection of large volumes or numerous fractions</li><li data-start="466" data-end="559">Suitable for SEC, AC, IEX, and HIC, with upscaling capabilities</li><li data-start="560" data-end="651">Automation: High-flow buffer delivery and mixing for large-scale purification tasks</li><li data-start="652" data-end="739">System design: Same footprint as <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1625">AZURA Lab FPLC systems</a> for compact scalability</li><li data-start="740" data-end="871">Software:<ul data-start="760" data-end="871"><li data-start="760" data-end="831">Intuitive and powerful PurityChrom® software in basic configuration</li><li data-start="834" data-end="871">21 CFR Part 11 compliant software</li></ul></li><li data-start="872" data-end="1069">Scalability:<ul data-start="895" data-end="1069"><li data-start="895" data-end="965">Configure your FPLC system based on your purification requirements</li><li data-start="968" data-end="1069">Scale-up is possible with the same flexibility and software while maintaining a minimal footprint</li></ul></li></ul>

KNAUER AZURA® SEC Compact System

The AZURA SEC Compact systems provide excellent price-to-performance value, ideal for labs entering GPC/SEC, process control, or those with limited budgets and educational needs.

<h3>Compact, versatile system for SEC and GPC applications&nbsp;</h3>The AZURA SEC Compact systems offer an outstanding price-to-performance ratio and are the perfect solution for every laboratory entering the analytical world of GPC/SEC, for process control applications, or for limited-budget and educational laboratories.The heart of the systems is the Assistant ASM 2.2L is a docking station for three compact devices. Valves, pumps and UV detectors can be combined in one housing. Routine maintenance work e.g. replacing the lamp of a detector is easily performed by the user.Thanks to its modular concept the systems can be extended with additional components at any time later.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_SEC_Compact_System_3_313d153f48.jpg" alt="KNAUER: AZURA® SEC Compact System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_SEC_Compact_System_3_313d153f48.jpg 237w," sizes="100vw" width="1009" height="664"><h3 data-start="857" data-end="879">Key Features</h3><ul data-start="880" data-end="1168"><li data-start="880" data-end="914">Flow rate: 0.001–10 ml/min</li><li data-start="915" data-end="946">Pressure: Up to 400 bar</li><li data-start="947" data-end="997">Intuitive operation with maximum precision</li><li>Injection via valve drive for minimal pressure spikes</li><li data-start="1043" data-end="1095">Supports a wide range of SEC and GPC columns</li><li data-start="1096" data-end="1128">Dedicated SEC/GPC ClarityChrom® add-on for in-depth data evaluation</li><li data-start="1129" data-end="1168">Expandable, space-saving design</li><li data-start="1129" data-end="1168">Suitable for organic and aqueous eluents</li></ul><h3 data-start="1175" data-end="1219">System Components &amp; Configurations</h3><ul data-start="1220" data-end="1486"><li data-start="1220" data-end="1242">Isocratic pump</li><li data-start="1243" data-end="1270">UV and RI detectors</li><li data-start="1271" data-end="1296">Column thermostat</li><li data-start="1297" data-end="1335">Automatic injection (optional)</li><li data-start="1336" data-end="1393">ClarityChrom® add-on for in-depth data evaluation</li><li data-start="1394" data-end="1486">Choose a hardware version for aqueous SEC of biomolecules or organic GPC of polymers</li></ul><h3 data-start="1493" data-end="1520">Detection Options</h3><ul data-start="1521" data-end="1555"><li data-start="1521" data-end="1555">RI, UV, ELSD, PDA, FLD, MS</li></ul><h3 data-start="1562" data-end="1587">Upgrade Options</h3><ul data-start="1588" data-end="1745"><li data-start="1588" data-end="1649">Automatic solvent recycle valve (cost-saving feature)</li><li data-start="1650" data-end="1666">Degasser</li><li data-start="1667" data-end="1686">Autosampler</li><li data-start="1687" data-end="1745">Additional detectors (RI, UV, ELSD, PDA, FLD, ECD)</li></ul>&nbsp;<figure class="image"><img style="aspect-ratio:1886/1452;" src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_SEC_Compact_System_3c56c6482f.webp" alt="KNAUER: AZURA® SEC Compact System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_SEC_Compact_System_3c56c6482f.webp 203w," sizes="100vw" width="1886" height="1452"></figure>

KNAUER AZURA® SEC Lab System

The AZURA SEC Lab systems are ideal for labs requiring top analytical performance, offering unmatched flow precision and ultra-low pulsation for exceptional retention volume accuracy and reproducibility.

<h3>Highest analytical performance and robustness for SEC and GPC applications</h3>The AZURA SEC Lab systems are the perfect choice for laboratories that demands highest analytical performance. The system shows unsurpassed flow precision paired with ultra-low pulsation for outstanding retention volume precision and reproducibility.The autosampler can inject from up to 768 positions via microtiter plates or 108 standard 1.5 ml sample vials and is therefore the perfect choice for larger sample amount as well as for high sample throughput laboratories. Thanks to the reliable and robust design it is the workhorse in any laboratory.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_SEC_Lab_System_e161ecef84.webp" alt="KNAUER: AZURA® SEC Lab System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_SEC_Lab_System_e161ecef84.webp 203w," sizes="100vw" width="1886" height="1452"><h3>Key Features</h3><ul><li>Injection volume: 1 –1000 µl&nbsp;</li><li>Easy maintenance</li><li>Great selection of SEC/GPC columns</li><li>Unsurpassed flow precision paired with ultra-low pulsation for</li><li>Highest analytical performance</li><li>Suitable for organic and aqueous eluents</li><li>Highest level of automation</li><li>Choose the matching hardware version for aqueous SEC of biomolecules or organic GPC of polymers</li></ul><h3>Upgrade Options</h3><ul><li>Save operating costs with an automatic solvent recycle valve</li><li>Degasser</li><li>Detector (RI, UV, ELSD, PDA, FLD, ECD)</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_SEC_Lab_System_2_2cbe13a95d.webp" alt="KNAUER: AZURA® SEC Lab System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_SEC_Lab_System_2_2cbe13a95d.webp 234w," sizes="100vw" width="953" height="635"> All wetted parts are available in either bioinert materials or for standard phase solvents.

KNAUER AZURA® SEC Semi-Prep System

The AZURA SEC Semi-prep systems enable fractionation of specific molecular weight ranges or purification tasks, with a pump delivering up to 50 ml/min, making it ideal for all semi-preparative GPC/SEC columns.

<h3>Automated system for semi-preparative SEC and GPC</h3>The AZURA SEC Semi-prep systems offer the possibility of fractionating specific molecular weight ranges or purification tasks. The pump can deliver flow rates of up to 50 ml/min and is therefore suitable for every semi-preparative GPC/SEC column.Thanks to the modular concept of the AZURA platform and the dedicated PurityChrom® software, the systems can be highly adapted to any separation task.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_SEC_Semi_Prep_System_12215b2eda.webp" alt="KNAUER: AZURA® SEC Semi-Prep System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_SEC_Semi_Prep_System_12215b2eda.webp 203w," sizes="100vw" width="1886" height="1452"><h3>Fraction Collection</h3>Collect large quantities or large numbers of fractions:<ul style="list-style-type:disc;"><li style="tab-stops:list 36.0pt;">Manually – collection by direct control</li><li style="tab-stops:list 36.0pt;">Volume-based – collection at defined volumes</li><li style="tab-stops:list 36.0pt;">Peak-based – collection according to detector signal</li><li style="tab-stops:list 36.0pt;">From switching valve to fraction collector solutions</li></ul><h3>Key Features</h3><ul><li data-start="70" data-end="134">Modular concept for any separation and purification task</li><li data-start="135" data-end="169">Flow rates: 0.01–50 ml/min</li><li data-start="170" data-end="249">Injection options: Manual or autosampler (up to 10 ml injection volume)</li><li data-start="250" data-end="320">Eluent compatibility: Suitable for organic and aqueous eluents</li><li data-start="321" data-end="390">Column selection: Wide range of SEC and GPC columns available</li><li data-start="563" data-end="649">Efficiency features: Automatic solvent recycle valve to reduce operating costs</li><li data-start="650" data-end="757">Hardware options: Choose a version for aqueous SEC (biomolecules) or organic GPC (polymers)</li><li data-start="758" data-end="813">Software options: ClarityChrom® or PurityChrom®</li></ul><h3>Available Detectors for Semi-prep</h3>The AZURA SEC Semi-prep systems can be equipped with a dedicated high-flow RI detector that can be used up to 10 ml/min as well as with the UV Detectors UVD 2.1S and UVD 2.1L.

KNAUER AZURA® GPC Cleanup System

Do not waste time and labor with manual sample preparation. The AZURA GPC Cleanup system automates work-intensive and time-consuming cleanup tasks based on gel permeation chromatography (GPC).

<h3>Save time with automatic sample preparation</h3>Do not waste time and labor with manual sample preparation. The AZURA GPC Cleanup system automates work-intensive and time-consuming cleanup tasks based on gel permeation chromatography (GPC). Further, reproducibility and quality of the cleanup are improved.After sample loading, the dedicated system fully automated processes up to 15 samples while requiring minimal bench space. Based on the versatile AZURA device platform the system can be customized to fulfill individual requirements. The cost-effective software Mobile Control provides a touch-optimized user interface for intuitive device control directly at the system.<img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_GPC_Cleanup_System_224a241335.webp" alt="KNAUER: AZURA® GPC Cleanup System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_GPC_Cleanup_System_224a241335.webp 203w," sizes="100vw" width="1886" height="1452"><h3>Key Features</h3><ul><li data-start="69" data-end="102">Flow rate: 0.01–10 ml/min</li><li data-start="103" data-end="169">Enhanced reproducibility – consistent and reliable results</li><li data-start="170" data-end="214">Handles viscous and complex matrices</li><li data-start="215" data-end="269">Fully automated processing of up to 15 samples</li><li data-start="270" data-end="320">Supports AOAC, EPA, and European Standards</li><li data-start="321" data-end="365">Adaptable to specific lab procedures</li><li data-start="366" data-end="405">Compact, space-efficient system</li><li data-start="406" data-end="466">Touch-optimized Mobile Control for device management</li><li data-start="467" data-end="551">Automated workflows for streamlined sample preparation and higher efficiency</li><li data-start="552" data-end="606">Optimized cleanup tasks for better performance</li><li data-start="607" data-end="658">Easily adaptable for different applications</li></ul><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/KNAUER_AZURA_GPC_Cleanup_System_2_27867ae999.jpg" alt="KNAUER: AZURA® GPC Cleanup System: Chromatogram of US EPA method 3640A calibration standard containing 1) Corn oil matrix 2) Bis-(2-ethylhexyl)phalate 3) Methoxychlor 4) Perylene." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_KNAUER_AZURA_GPC_Cleanup_System_2_27867ae999.jpg 245w," sizes="100vw" width="1247" height="626">In accordance with established methods to determine pesticide residues<ul><li>Method 984.21 – AOAC international</li><li>EPA SW-846 Method 3640A – US Environmental Protection Agency</li><li>AEN 12393 and EN 1528 – European Standard</li><li>L 00.00-34 Method in accordance with §64 LFGB (formerly § 35 LMBG)</li></ul>

Products from KNAUER - page 7

Related content

Webinars LabRulezLCMS Week 20/2026

Cerebrospinal Fluid Proteome Reveals Dysregulation of Lysosomal and Axonal Proteins in Neurosyphilis

A Rare Genetic Disorder in the Amish Community Helped Confirm a Key Cellular Mechanism